Dresden-based anvajo, a technology company that develops, manufactures and sells innovative solutions for analysing liquids, announced that it has raised €17.7M in a Series A round of funding to support “the launch into the human medicine markets.”
The investment came from pharmaceutical company MEDICE Arzneimittel Pütter GmbH & Co. KG, the Johnsonville Holdings, Inc. fund, and German diagnostics specialists Elber Beteiligungen and Think.Health. Besides, Die BrückenköpfeX also participated in the round.